A potential region of SMAD3 binding within an intron of C1orf106 was identified in a SMAD2/3 ChIP-sequencing analysis of TGF-β target genes in MII breast cancer cells (Figure S2) [34]. The gene discussed is SMAD2; the disease is breast carcinoma.